您所在的位置: 首页 >> 专家介绍 >> 盛晓燕
科室导航

盛晓燕 副主任药师

科室: 药剂科

擅长:定量药理学、群体药代动力学、治疗药物监测相关个体化药物治疗 更多>>
手机扫一扫

个人简介 学术任职 学术论著 专家风采

北京大学医学部临床药学专业硕士毕业,现为肾内科专业临床药师,中国医院协会药事管理专业委员会认证临床药师及师资培训基地带教师资,北京市规范化培训学员带教师资。作为项目执行负责人,完成十余项新药I期临床试验,参于十三五“重大新药创制科技重大专项”,北京市研究型病房建设项目,首都特色应用研究专项课题等多项课题。

任中国药理学会定量药理学专业委员会委员,中国药理学会治疗药物监测研究专业委员会第二、三届青年委员会常委,中国药理学会治疗药物监测研究专业委员会第一届临床药师学组秘书,北京医学会罕见病分会第二届临床评价药学组委员,中国药理学会药物临床试验专业委员会青年委员会委员,《临床药物治疗学杂志》、《中国药业》青年编委等社会职务。

1.Sheng XY, Xie R, Wei LH, Jia B, Li YF, Zheng ZG, Zhao X, Cui YM. A first-in-human study of Brozopentyl Sodium, following single and multiple ascending intravenous infusion in Chinese healthy volunteers. Eur J Pharm Sci. 2024; 192:106663. doi: 10.1016/j.ejps.2023.106663. 

2.Feng P, Sheng XY#(共一), Ji Y, Urva S, Wang F, Miller S, Qian C, An Z, Cui Y. A Phase 1 Multiple Dose Study of Tirzepatide in Chinese Patients with Type 2 Diabetes. Adv Ther. 2023; 40(8):3434-3445. doi: 10.1007/s12325-023-02536-8.

3.Sheng XY, Liu ZY, Zhao J, Song L, Zhao WM, Zhao X, Cui YM. Safety, tolerance, pharmacokinetic and pharmacodynamic properties of thrombopoietin mimetic peptide for injection in Chinese healthy volunteers: a randomized, placebo-controlled, double-blind study. Platelets. 2022;33(8):1185-1191. doi: 10.1080/09537104.2022.2073344. 

4.Sheng XY, Liang Y, Yang XY, Li LE, Ye X, Zhao X, Cui YM. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers. Eur J Clin Pharmacol. 2020; 76(3):383-391. doi: 10.1007/s00228-019-02800-3. 

5.Zhao X, Sheng XY#(共一), Payne CD, Zhang X, Wang F, Cui YM. Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study. Clin Pharmacol Drug Dev. 2020; 9(8):952-960. doi: 10.1002/cpdd.868.

6.Sheng XY, Chen CY, Ma LY, Liu YO, Zhou Y, Cui YM. Population pharmacokinetics of vancomycin in Chinese infants. Int J Clin Pharmacol Ther. 2017; 55(7):558-566. doi: 10.5414/CP202827.